Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD
Han Zhang, Qinghui Niu, Kun Liang, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 4599-4608
Open Access | Times Cited: 21

Showing 21 citing articles:

LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review
Qingmin Zeng, Changhai Liu, Dongbo Wu, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 560-560
Open Access | Times Cited: 30
Identification and Assessment of lncRNAs and mRNAs in PM2.5-Induced Hepatic Steatosis
Peng Tian, Hui Xia, Xin-Bao Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2808-2808
Open Access | Times Cited: 1
Evaluation of altered miRNA expression pattern to predict COVID-19 severity
Swati Srivastava, Iti Garg, Yamini Singh, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e13388-e13388
Open Access | Times Cited: 14
Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome
Yong Chen, Leikai Ma, Zhouling Ge, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 20
Cracking the code: lncRNA-miRNA-mRNA integrated network analysis unveiling lncRNAs as promising non-invasive NAFLD biomarkers toward precision diagnosis
Nouran Yonis, Ahmed Mousa, Mohamed H. Yousef, et al.
Computational Biology and Chemistry (2025) Vol. 115, pp. 108325-108325
Closed Access
Intestinal IncRNAs and circRNAs Regulated by Dietary‐Lipid Stimuli
Luis A. Chapado, M. Carmen Crespo, João Tomé‐Carneiro, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
Mechanisms of Epigenetic Regulation in the Fibrogenic Activation of Hepatic Stellate Cells in Non-alcoholic Fatty Liver Disease
Dmitry Victorovich Garbuzenko
Gene Expression (2024) Vol. 23, Iss. 1, pp. 31-43
Open Access | Times Cited: 3
Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease
Mirolyuba Ilieva, James Dao, Henry E. Miller, et al.
Non-Coding RNA (2022) Vol. 8, Iss. 4, pp. 56-56
Open Access | Times Cited: 15
LncRNA PVT1 mediates the progression of liver necroptosis via ZBP1 promoter methylation under nonylphenol exposure
Qiannan-Di, Qianqian-Jiang, Jiahui-Sun, et al.
The Science of The Total Environment (2022) Vol. 844, pp. 157185-157185
Closed Access | Times Cited: 13
Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis
Henry Wade, Kaichao Pan, Bingrui Zhang, et al.
eGastroenterology (2024) Vol. 2, Iss. 4, pp. e100115-e100115
Open Access | Times Cited: 2
LncRNA ZFAS1 ameliorates injury led by non-alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation
Lu Liu, Sen Sun, Xiaohua Li
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 47, Iss. 1, pp. 102067-102067
Closed Access | Times Cited: 9
The Association between the Differential Expression of lncRNA and Type 2 Diabetes Mellitus in People with Hypertriglyceridemia
Shoumeng Yan, Nan Yao, Xiaotong Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4279-4279
Open Access | Times Cited: 4
Molecular Insights of Nonalcoholic Fatty Liver Disease Pathogenesis
Reham Mohammed Dawood, Ghada M. Salum, Mai Abd El-Meguid, et al.
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 3, pp. 111-123
Closed Access | Times Cited: 1
Expression of PVT-1 and miR-29a/29b as reliable biomarkers for liver cirrhosis and their correlation with the inflammatory biomarkers profile.
Shaza E. Khalaf, Shima N. Abdelfattah, Amal K. Khaliefa, et al.
Human & Experimental Toxicology (2024) Vol. 43
Open Access | Times Cited: 1
Holistic expression of miR-17-92 cluster in obesity, kidney diseases, cardiovascular diseases, and diabetes
Maheen Ejaz, Syed Mohammad Usman, Saira Amir, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 8, pp. 6913-6925
Closed Access | Times Cited: 3
LncRNA PVT1 as a Novel Biomarker for Diabetes-related Complications
Xinyan Qiu, Jinlan Chen, Jingjie Yang, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 6, pp. 688-696
Closed Access | Times Cited: 2
Inflammatory MicroRNAs and the Pathophysiology of Endometriosis and Atherosclerosis: Common Pathways and Future Directions Towards Elucidating the Relationship
Zubeen Azari, Fatimah Aljubran, Warren B. Nothnick
Reproductive Sciences (2022) Vol. 29, Iss. 8, pp. 2089-2104
Closed Access | Times Cited: 4
Integrated multi-omics analysis reveals miR-20a as a regulator for metabolic colorectal cancer
Kai Song, Chao Liu, Jiashuai Zhang, et al.
Heliyon (2022) Vol. 8, Iss. 3, pp. e09068-e09068
Open Access | Times Cited: 3
Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?
Sina Kalantari Soltanieh, Sahar Khastar, Irwanjot Kaur, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access
Plasmacytoma Variant Translocation 1 (PVT1) Gene as a Potential Novel Target for the Treatment of Diabetic Nephropathy
Helen Mok, Ahmed M. Al‐Jumaily, Jun Lu
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2711-2711
Open Access | Times Cited: 2
Evaluation of altered miRNA expression pattern to predict COVID-19 severity.
Swati Srivast, Iti Garg, Yamini Singh, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Page 1

Scroll to top